PubMed Health⌕ Search

Biomedical subjects

A Noworolska

Publications and source records attributed to A Noworolska.

At least 19 recordsLinked to original sources
PubMed2000

Increased interleukin-7 levels in the sera of psoriatic patients: lack of correlations with interleukin-6 levels and disease intensity.

Interleukin (IL)-7 is a multifunctional cytokine which is involved in the regulation of keratinocyte-T lymphocyte interactions; the latter is an important factor in the pathogenesis of psoriasis. In vitro, IL-7 is able to induce release of cytokines, including IL-6; IL-6 expression is known to be enhanced in psoriatic patients. Serum levels of IL-7 and IL-6 were measured by ELISA in 40 psoriatic patients and compared with cytokine levels in 18 healthy individuals. Serum levels of IL-7 were also evaluated in 24 psoriatic patients during the remission of the disease after effective treatment. The IL-7 and IL-6 serum levels were significantly higher in psoriatic patients than in healthy subjects and the IL-7 serum levels did not significantly decrease after treatment. Serum levels of IL-7 did not correlate with PASI scores; however, a significant positive relationship was observed between IL-6 levels and PASI scores. There was no correlation between increased levels of IL-7 and IL-6 in the sera of psoriatic patients, suggesting the lack of a direct link between these two cytokines in the psoriatic process. In conclusion, increased IL-7 serum levels suggest that IL-7, like IL-6, may be involved in the pathogenesis of psoriasis, but in contrast with IL-6, serum IL-7 levels could not be used as a marker of disease activity in psoriatic patients.

Administration, Topical↗
PubMed1999

Soluble E-selectin serum levels correlate with disease activity in psoriatic patients.

E-selectin is an adhesion molecule expressed on vascular endothelial cells in several inflammatory skin diseases, including psoriasis. It is responsible for the adherence between microvascular endothelium and neutrophils, monocytes, eosinophils and subsets of T cells. Soluble E-selectin (sE-selectin) serum levels were measured by ELISA in 32 psoriatic patients before treatment and compared with both post-treatment sE-selectin levels in 16 patients and sE-selectin values in 10 healthy individuals. Soluble E-selectin serum levels were significantly increased in psoriatic patients compared with healthy persons. Moreover, a significant correlation was demonstrated between sE-selectin values and PASI scores. No relationship was found between sE-selectin levels and duration of psoriasis. Soluble E-selectin serum levels decreased significantly after treatment of psoriasis. This phenomenon was more evident in patients with more severe psoriasis. In conclusion, sE-selectin serum levels correlate with the extent of psoriatic lesions and could be used as marker of the disease activity in psoriatic patients.

Adolescent↗
PubMed1991

Distribution of carbohydrate structures in individual maturation stages of myeloid leukemic cells.

The distribution of peanut agglutinin (PNA) receptors, nonspecific cross-reacting antigen (NCA) molecule and 3-fucosyl-N-acetyllactosamine (FAL) in myeloid leukemic cells isolated by density gradient centrifugation was compared using immunofluorescence test (IF). Patients with acute myelocytic leukemias (AML) type M2 and M5 showed low percentage of NCA+ and PNA+ cells. In chronic and acute phase of chronic myelocytic leukemias (CML) the number of NCA containing cells increased and the amount of PNA-binding cells decreased as more mature granulocytic fractions were isolated on Ficoll--Uropoline density gradient. In patients with myeloblastic crisis of CML (CML-BC) the number of cells expressing FAL structure did not change in relation to maturation stage of myeloid cells. Our results revealed that the expression of various markers could change in a different way during the differentiation of cells from myeloblasts to mature granulocytes.

Antigens, Neoplasm↗
PubMed1990

Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia.

Cytogenetic analyses were carried out on peripheral blood and bone marrow cells of 31 chronic myeloid leukemia (CML) patients who presented with blastic, accelerated, or chronic phases. The percentage of cytoplasmic nonspecific cross-reacting antigen (cNCA, a marker of myelocytic differentiation)-containing cells was determined in the same blood or bone marrow samples. The patients were divided in two groups according to cytogenetic results: those with aberrations in addition to the Philadelphia chromosome (Ph1) and those with Ph1 only. Among the additional aberrations such changes, not typical of CML, were found: del(2)(p21), t(6;11)(q25;q23), and t(12;?)(p13;?). The survival time and the percentage of cNCA-positive cells of patients in blastic and accelerated phases were compared between the above-mentioned two groups of patients using the Student t test and the Kaplan-Meier estimator. The percentage of cNCA-positive cells was significantly lower and the survival time significantly shorter in the group of patients with additional aberrations. The probability of survival according to the Kaplan-Meier estimator was also lower for this group. These data suggest that the immunologically determined lower degree of maturity, that characterized cells bearing additional aberrations, coincides with and/or results in more rapid progression of the disease.

Adult↗
PubMed1989

Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.

The reactivity of two monoclonal antibodies recognizing NCA-95 and NCA-55 (MAb 47 and MAb 192, respectively) with a polyclonal anti-NCA serum in myeloid leukemic cells isolated by density gradient centrifugation was compared using an immunofluorescence test (IF). It was observed that the blood myeloid cells in 78.8% of the patients with different types of myelocytic leukemias and all granulocytes of 15 normal donors showed similar expression of the NCA species studied. The leukocytes of the remaining patients did not synthesize the NCA-95 species regardless of the maturation stage of the cells studied. In two patients, synthesis of this NCA form was limited to the fractions containing myelocytes and metamyelocytes. We have found that all anti-NCA antibodies studied recognized different antigenic epitopes in a myeloid cell series. A relationship between the patient's survival and the proportion of NCA-containing cells was also observed.

Antibodies, Monoclonal↗
PubMed1989

Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA).

The effect of LD Ara-C (10(-8) mol/l) (Ara-C), TPA (1.6 x 10(-7) mol/l) and 13-cis-retinoic acid (RA) (10(-6) mol/l) on the differentiation in liquid culture of bone marrow cells from 5 patients with acute lymphoblastic, 17 patients with acute myelogenous leukemia, 1 patient in myeloid and 1 in lymphoid crisis of chronic granulocytic leukemia was studied. Ara-C induced morphological and cytochemical differentiation into monocytic cells in 2 cases (M1, M5 type). TPA induced convincing morphological and cytochemical features of maturation into monocytic cells in 4 cases (two M1, one M2, and one M5 type) and into differentiated myeloid cells in 2 cases (M1, M4 type). RA in one case (M2 type) out of three AML studied induced cytochemical and immunocytochemical features of maturation. The results of the study indicate that although TPA is a better inducer of blast cell differentiation than Ara-C, however, neither is a potent differentiation agent of leukemic blasts in liquid culture. The heterogeneity of leukemic blasts within the same type of leukemia was confirmed by their different response to differentiating agents.

Antigens, Neoplasm↗
PubMed1987

Morphologic heterogeneity of cell populations isolated by density gradient centrifugation from serous fluids of ovarian tumors.

The cells of tumor fluid from patients with malignant and benign serous ovarian neoplasms were fractionated using Ficoll-Uropoline density gradient centrifugation. Density distribution and morphologic characteristics of cell fractions were analyzed. It was found that serous ovarian adenocarcinomas contained three to four types of morphologically malignant cells focused in low density layers. Borderline ovarian neoplasms showed the presence of one subpopulation of cells with some features of malignancy and cells with some atypical but non-malignant features. The fluids of serous cysts contained mainly normal epithelial cells representing different stages of morphological maturity and were focused in denser layers. The results allowed us to catalogue ovarian tumor cell subpopulations present in each density fraction of individual patients and confirmed that ovarian tumors could be diagnosed by morphologic identification of cells from tumor fluids.

Adult↗
PubMed1986

Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.

Discontinuous density-gradient centrifugation was used to separate myeloid cells of different myelocytic leukemias [acute myelocytic leukemia (AML), chronic granulocytic leukemia (CGL), and chronic granulocytic leukemia in blast crisis (CGL-BC)] into fractions containing granulocytes in individual stages of maturation. The distribution of surface nonspecific cross reacting antigen (sNCA), and cytoplasmic NCA (cNCA) in each cell fraction was estimated by immunofluorescence (IF), and the influence of proteolytic enzymes and neuraminidase on sNCA presence was analyzed. It was found that the percentage of sNCA- and cNCA-positive cells increased in more mature granulocyte fractions; only in the morphologically oldest granulocytes did the number of sNCA-positive cells decrease, probably as a result of the rise of NCA secretion into body fluids; proteolytic enzymes caused an increasing number of sNCA-expressing cells; and neuraminidase treatment usually reduced the percentage of sNCA-positive cells.

Antigens, Neoplasm↗
PubMed1985

Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.

The distribution and localization of NCA and carcinoembryonic antigen CEA in cells of different types of myelogenous leukaemias (acute myelogenous leukaemia - AML; chronic granulocytic leukaemia - CGL; CGL in myeloblastic crisis - CGL-BC) was studied using the immunofluorescence test. Discontinuous density-gradient centrifugation was used to separate myeloid cells into fractions containing granulocytes in individual stages of maturation. Serum NCA and CEA levels were estimated in parallel. It was established that: (a) AML blasts without maturation (MO type) and monoblasts did not synthesize NCA; (b) individual blasts of AML with features of maturation (M1, M2 types) and some myeloblasts of CGL-BC exhibited a limited ability to express cytoplasmic NCA; (c) the number of NCA-containing cells increased in the more mature granulocyte fractions isolated on Ficoll-Hypaque density-gradients; (d) myelocytic NCA is immunologically related to NCA isolated from lung tissue and (e) CEA is undetectable in the myelocytic cell series.

Antigens, Neoplasm↗
PubMed1984

Immunological typing of blast cells. Cases with pre-B cell characteristics.

Leukemic cells from 32 patients were examined by using conventional immunological markers (E and EAC rosettes, surface immunoglobulins). Additionally, the test for intracytoplasmic IgM, Fc IgG receptor and the presence of light chains were performed. Leukemic blasts of all patients were investigated according to morphological and cytochemical criteria. Lymphoblasts from 3 patients had pre-B cell phenotype: cIgM +, sIg-. Each of 3 patients with pre-B cell characteristics had different diagnosis and different morphological and cytochemical features of the leukemic cells (ALL, NHL and CML). In 24 ALL cases the diagnosis of non-T, non-B ALL, in 4 cases T-ALL and in one B-ALL was established. The correlation of cytochemical results with special reference to acid phosphatase and immunological subclasses of ALL was also analyzed. An important question is raised with regard to diagnostic classification and treatment by finding ALL phenotypes in lymphoproliferative disorders that are not diagnosed as ALL.

B-Lymphocytes↗
PubMed1982

High and low Fc IgG-receptor expression in human chronic granulocytic leukaemia cells.

Discontinuous density-gradient centrifugation was used to separate chronic granulocytic leukaemia (CGL) cells in the chronic phase and blast crisis (BC) into fractions containing granulocytes in individual stages of maturation. The occurrence of the Fc IgG (FcR) and complement-component receptors (CR1 and CR2) in each fraction was estimated. It was established that, with increasing yields of mature granulocytes, the proportion of cells bearing Fc and C3 receptors increased. The most important finding was that the high- and low-receptor categories of CGL cells in chronic phase depended on the percentage of FcR+ cells. In the high-receptor CGL group, in addition to FcR, the proportion of CR1+ and CR2+ cells was also greater than in the low-receptor CGL group. Some differences in clinical course of both immunological CGL groups were observed.

Adult↗
PubMed1980

Fc and C3 receptors as membrane differentiation markers of acute myelogenous leukaemia cells.

Acute myelogenous leukaemia cells (AML) and cells of chronic myelogenous leukaemia blast crisis (CGL-CB) were examined for the presence of receptors for Fc IgG fragment (FcR), receptors for the complement components (CR1 and CR2), and the surface immunoglobulins including the light kappa and lambda type chains. The leukaemia blasts were found to be the cells poor in receptors and poorly differentiated. As a rule, they contained very small amount of detectable FcR, CR2, and CR1. Analysis of AML cell populations separated on the discontinuous density gradient revealed that the appearance of FcR was followed by CR2 and CR1. The CGL-CB cells were more differentiated immunologically since, in comparison with the AML cells, in greater percentage they expressed the FcR, and the receptors for complement. Assays for surface immunoglobulins indicated that they were not an active product of the leukaemic blasts, but rather exogenous in origin.

Complement C3↗
PubMed1980

Antibody-dependent redistribution and release of immunological complexes in cells of human chronic leukemias.

Redistribution and the ability for removing immunological complexes in CLL and CGL cells treated with the specific anti-leukemia antigens were investigated. The immunofluorescence method at 4 and 37 degrees C was applied at different times of cell incubation with antigens. It was shown, that incubation at 4 degrees C even carried out for 18 h, neither caused a clear aggregation nor a release of immunological complexes from the leukemia cell surface, whereas at 37 degrees C considerable differences in mobility of CLL and CGL cells were observed. In CGL cells quite a rapid redistribution followed by the removal of antigen-antibody complexes was observed, while CLL cells have shown the ability for aggregation only, without clear polarization and without releasing the formed complex from the cell surface.

Antigen-Antibody Complex↗
PubMed1980

Surface immunoglobulins in human chronic leukemia cells.

By means of the cytotoxic and immunofluorescence tests, frequency of various classes of immunoglobulins (IgG, IgA, IgM, IgD, IgE) and light chains was examined in peripheral pathologic blood cells of patients with chronic granulocytic and lymphatic leukemia. The dominant immunoglobulins were of the IgD and IgE classes. Light chains of both types were present in cells of chronic granulocytic leukemia, and kappa type in chronic lymphatic leukemia. Use of the method of resynthesis of digested immunoglobulins in vitro confirmed the monoclonal origin of chronic lymphatic leukemia in humans.

Granulocytes↗
PubMed1980

Relationship between different cell surface markers in chronic lymphocytic leukemia.

Peripheral blood lymphocytes from 15 patients with chronic lymphocytic leukemia (CLL) and 13 normal controls were examined for the presence of surface markers: CLL antigen, surface immunoglobulins, receptors for sheep erythrocytes, receptors for the IgG Fc, C3b, C3d and receptor(s) for mouse erythrocytes. Leukemic lymphocytes were characterized by the presence of CLL antigen and a significant increase in the capacity to bind mouse erythrocytes. CLL antigen was correlated with surface immunoglobulins and receptor of IgG Fc, however, the receptor for mouse red cells was not correlated with other surface markers. Neuraminidase treatment of CLL lymphocytes significantly increased proportion of mouse erythrocyte rosettes. The routine use of mouse erythrocyte rosettes in the immunodiagnostics of B lymphoproliferative disorders is postulated.

Animals↗